Comparison of Xelox with Folfox Chemotherapy in Patients with Non-Metastatic Colon Cancer

ABSTRACT: Intervention 1: Intervention group:Xelox diet group.Includes a 2-hour intravascular injection. Oxaliplatin injection of 130 mg / m2 on day 1 plus oral capsaicin 1000 mg / m2 twice daily on days 15-1 of the 3-week cycle on an outpatient basis. The first dose of capsaicin is given in the evening of day 1 and the last dose in the morning on day 15 (28 doses per cycle). Intervention 2: Control group:Folfox diet group.Includes weekly injections of 5 FU 500 mg / m2, Leucovorin 500 mg / m2 for 6 weeks and oxaliplatin 85 mg / m2 at weeks 1, 3, 5, repeated for 3 periods. Primary outcome(s): Local recurrence. Timepoint: One year period. Method of measurement: Colonoscopy.;Distant metastasis. Timepoint: One year period. Method of measurement: Tumor marker and CT scan. Study Design: Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are divided into two groups a and b using the balance block randomization method. The size of each block is 4. The method of balanced randomization allocation for participants in a randomized clinical trial study is the effect of Xelox (group a) and Folfox (group b) chemotherapy on reducing local recurrence and distant metastasis of non-metastatic colon cancer patients.The tool is random allocation software.

DISEASE(S): Colorectal Cancer,Malignant Neoplasm Of Colon

PROVIDER: 2727549 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR